C

Centrul Medical Sana | Bucharest, Romania

Research site

(Unclaimed)

Location

No 3-5 Dr Sergiu Dumitru Street, Bucharest, București, Romania

Site insights

Top conditions

Top treatments

Zonisamide

Prucalopride

CHF5993

Cladribine

Verekitug

Molnupiravir

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 8 total trials

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023) (MOVe-NOW)

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most often causes mild flu or cold-like symp...

Enrolling

Coronavirus Disease (COVID-19)

Drug: Placebo

Drug: Molnupiravir

A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease (UplighTED)

This study aims to evaluate the efficacy, safety and tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of efgartigimod P...

Enrolling

Thyroid Eye Disease

Other: Placebo PH20 SC

Combination Product: Efgartigimod PH20 SC

A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

The purpose of this study is to assess the efficacy and safety of verekitug (UPB-101) in participants with moderate-to-severe Chronic Obstructive Pul...

Enrolling

Chronic Obstructive Pulmonary Disease

Other: Placebo

Drug: Verekitug